Consumer Packaged Goods, Food & Household Brands · Advertiser / Brand
Medtronic
Global medical device and healthcare technology manufacturer.
Available information varies by company and source.
Profile record updated:
Company facts
- Official name
- Medtronic plc
- Entity type
- COMPANY
- Founded
- 1949
- Headquarters
- Ireland
- Company size
- >5,000
- Market cluster / sector
- Consumer Packaged Goods, Food & Household Brands
- Market role
- Advertiser / Brand
- Ticker
- MDT
- Official website
- medtronic.com
What Medtronic does
Medtronic operates a diversified medical technology model built around designing, manufacturing, and commercialising medical devices and therapies for clinical use. It creates value by supplying essential products used in diagnosis, treatment, monitoring, and surgical intervention, then monetises through product sales into healthcare procurement channels and long-term institutional relationships.
Category differentiation
Medtronic is a medical technology manufacturer, not an advertising, media, or marketing software company. It sells clinical devices and therapies to healthcare buyers rather than digital marketing infrastructure.
Strategic context
AI-supported assessment from the existing company research; distinguish interpretation from sourced facts.
Medtronic plc is a publicly listed healthcare technology company headquartered in Ireland. It develops, manufactures, and sells medical devices and therapy systems used by hospitals, clinicians, and health systems across multiple care areas. The business is not an adtech, martech, or media company; it is a large-scale medtech manufacturer and commercial operator. The company generates revenue primarily from the sale of medical devices, procedure-related products, and therapy platforms to healthcare providers and institutional buyers. Its customer base is predominantly enterprise healthcare organisations, with downstream patient impact through the use of its products in clinical settings. Its public listing, long operating history, and large workforce position it as an established global incumbent rather than a high-growth software pure play.
Company news briefing
Briefing updated:
Medtronic is advancing the full separation of MiniMed Group through a dedicated exchange offer while reporting robust Q1 FY2027 net sales of $9.756 billion, supported by strategic acquisitions in its neuroscience portfolio. The board also approved a second-quarter cash dividend of $0.72 per ordinary share. Regionally, the company's communications are being supported by FINN Partners' newly established Minneapolis office.
Business model & monetisation
Medtronic monetises primarily through one-time and repeat sales of medical devices, implantable products, therapy systems, and procedure-linked clinical technologies. Commercial revenue is driven by enterprise healthcare procurement, long sales cycles, and ongoing replacement or utilisation of device-related products within care delivery settings.
- Medical devices and therapy systems
- One-time product sales to healthcare providers and institutions
Products & capabilities
No products with linked sources are available in this view.
Unlock Full Intelligence Profile for Medtronic
Get unlimited access to corporate ownership, historical M&A transactions, verified tech stack telemetry, and live market signals in the interactive Knowledge Graph.
Verified Ownership & Corporate Hierarchy
Complete corporate hierarchy traversal, shareholder cap table history, and parent holding links sourced from regulatory filings.
360° Tech Stack & Vendor Telemetry
Technical header bidding configurations, sellers.json registry nodes, CMP disclosures, and direct programmatic supply chains.
Live Market Signals & Executive Briefings
Continuous 24/7 monitoring of material M&A deals, executive shifts, product rollouts, and hiring trends across peer entities.
Competitors & alternatives
Track competitor shifts
Receive automated telemetry on strategic moves, acquisitions, and market share shifts across Medtronic's competitive landscape.
Large public healthcare manufacturer and commercial products company.
Biopharmaceutical company developing and commercialising prescription medicines.
Dutch health technology company serving providers and consumers.
Global pharmaceutical company selling medicines and vaccines.
Global family-owned healthcare group spanning aesthetics, therapeutics and lifecare.
Side-by-side comparisons
Recent recorded signals
Dates refer to the source publication. Older entries are historical context, not evidence of a new event.
XRlabs Raises €7.48M for AI Surgical Intelligence
HealthTech · Recorded impact score: 2/5
London-based XRlabs, a Surgical Intelligence company founded by neurosurgeon Dr. Ali Haddad, has raised €7.48 million ($8.4 million) in Seed funding. The round was led by Playground Global (Palo Alto), with participation from London-based HealthTech investor Eka Ventures. The company develops modular, device-agnostic software that uses computer vision and deep learning to transform live surgical video, navigation telemetry, and pre-operative imaging into a real-time, anatomy-aware view. Its platform has been deployed in over 100 surgical cases across three continents. The funding will support engineering and clinical team expansion, regulatory advancement in the UK, EU, and US, and the extension of clinical evidence. XRlabs also announced Omar Ishrak, former CEO of Medtronic, as Chair of its Board. The company has been awarded compute allocation on the UK AI Research Resource (AIRR).
- XRlabs raised €7.48 million ($8.4 million) in Seed funding led by Playground Global with participation from Eka Ventures.
- Omar Ishrak, former CEO of Medtronic, joined as Chair of XRlabs' Board of Directors.
Medtronic Announces Final Exchange Ratio of 4.5939 in Split-Off of MiniMed Group, Inc.
Recorded impact score: 4/5
Medtronic plc (Medtronic; NYSE: MDT) today announced the final exchange ratio for its previously announced offer to exchange outstanding Medtronic ordinary shares for shares of common stock of MiniMed Group, Inc.
8-K Financial Filing Analysis for Medtronic (2026-09-17)
financials · Recorded impact score: 3/5
On September 17, 2026, Medtronic plc filed a Form 8-K to correct a procedural disclosure error regarding its ongoing exchange offer initiated on September 14, 2026. The transaction involves offering up to 225,361,295 newly issued shares of MiniMed Group, Inc. common stock in exchange for outstanding Medtronic ordinary shares, facilitating the separation of MiniMed Group. The filing amends the guaranteed delivery deadline in the prospectus: executed notices of guaranteed delivery expire at 5:00 p.m. NYC time on the second NYSE trading day following execution, correcting a previous typographical error that stated 12:00 midnight.
- Medtronic is conducting an exchange offer for up to 225,361,295 newly issued common shares of MiniMed Group, Inc. in exchange for Medtronic ordinary shares, commenced on September 14, 2026.
- If oversubscribed, Medtronic may accept additional validly tendered shares up to 2.0% of total outstanding ordinary shares to dispose of its entire remaining stake in MiniMed.
Medtronic Launches Exchange Offer to Complete Separation of MiniMed Group, Inc.
Recorded impact score: 4.5/5
Medtronic shareholders can exchange their Medtronic ordinary shares for shares of MiniMed. Provides Medtronic shareholders with option for a generally tax-free exchange for U.S. federal income tax...
FINN Partners Opens Minneapolis Office, Expanding Midwest Presence
Corporate Expansion · Recorded impact score: 1/5
FINN Partners, a global independent marketing and communications firm, has opened a new office in Minneapolis, its fifth location in the Midwest and 39th worldwide. The office is staffed by a 10-person team and led by four senior partners: Greg Swan, Laura Anderson Sanchez, Carrie Young, and David Krejci. The team will serve clients including Hormel Foods, Medtronic, and Life Time. The expansion reflects FINN's growth in the region and its focus on integrated services such as social, influencer, digital marketing, and Generative Engine Optimization (GEO) to help brands gain visibility in AI-driven search environments. Dan Pooley, Founding Managing Partner for the Midwest, oversees the new office.
- FINN Partners opened a new office in Minneapolis, its fifth in the Midwest and 39th worldwide.
- The office has a 10-person team supported by four senior partners.
Explore company relationships
Questions about Medtronic
What is Medtronic?
Medtronic is a publicly listed healthcare technology company that develops and sells medical devices and therapy systems.
Who uses Medtronic?
Hospitals, health systems, clinics, surgeons, and other healthcare providers use Medtronic products in patient care.
How does Medtronic make money?
Medtronic makes money primarily by selling medical devices, implantable products, and therapy platforms to healthcare institutions.
Sources & coverage
This profile uses public, official and technically observable information. Missing information does not prove that a product or relationship does not exist. The list below does not imply that every profile statement has been verified.
6 publicly documented primary sources and citations linked across the market graph.
Continue your research on Medtronic
Open additional company details, personal Watchlists and your Strategic Intelligence Agent in Polaris7. It monitors your market daily and delivers tailored briefings with clear strategic context whenever relevant news occurs.
Daily intelligent monitoring · Verified primary sources.
Unlock full intelligence profile, ownership & live market signals